scholarly journals Implications of Historical Evidence for the Classification of Eating Disorders

1994 ◽  
Vol 165 (3) ◽  
pp. 287-292 ◽  
Author(s):  
William Li. Parry-Jones ◽  
Brenda Parry-Jones
Keyword(s):  
Eating Disorders ◽  
Temporal Distribution ◽  
Classification Systems ◽  
World Health ◽  
Major Influence ◽  
Historical Evidence ◽  
Icd 10 ◽  
Clinical Detail ◽  
Health Organization

Successive editions of the ICD and DSM classification systems have exercised a major influence over contemporary diagnostic practice and perceptions of the form and structure of disorders. Periodic revision has been based on clinical and epidemiological research, and minimal attention has been given to any possible contribution from historical evidence. To test the potential value of such evidence, the historical manifestations of four eating disorders (anorexia, bulimia, rumination and pica) were considered in relation to the clinical descriptions and diagnostic criteria of DSM–III–R (American Psychiatric Association, 1987) and ICD–10 (World Health Organization, 1992). For each disorder, evidence is presented of continuities and discontinuities with the phenomena recognised currently. Instances of symptom overlap between disorders and the implications of the historical findings for some current classificatory issues are discussed. When spread over several centuries, case numbers remain relatively small, the amount of clinical detail is highly variable, and temporal distribution is uneven. The conclusions that can be drawn, therefore, are necessarily somewhat tentative and subjective.

Lung Tumors With Neuroendocrine Morphology: Essential Radiologic and Pathologic Features

2008 ◽  
Vol 132 (7) ◽  
pp. 1055-1061 ◽  
Author(s):  
Teri J. Franks ◽  
Jeffrey R. Galvin
Keyword(s):  
Neuroendocrine Tumors ◽  
Classification Systems ◽  
World Health ◽  
National Library ◽  
Molecular Features ◽  
Distinct Subset ◽  
Pathologic Features ◽  
The World ◽  
Health Organization

Abstract Context.—Tumors with neuroendocrine morphology are a distinct subset of lung neoplasms sharing characteristic histologic, immunohistochemical, ultrastructural, and molecular features. Objective.—To review the current histologic classification and the diagnostic criteria for the major categories of neuroendocrine tumors of the lung. Data Sources.—Published classification systems from the World Health Organization and pertinent peer-reviewed articles indexed in PubMed (National Library of Medicine) form the basis of this review. Conclusions.—Accurate classification of the neuroendocrine tumors of the lung requires knowledge of specific criteria separating the major categories, which is essential for determining prognosis and treatment.

scholarly journals IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME

2015 ◽  
Vol 7 ◽  
pp. e2015035 ◽  
Author(s):  
Rosangela Invernizzi ◽  
Federica Quaglia ◽  
Matteo Giovanni Della Porta
Keyword(s):  
Molecular Techniques ◽  
Classification Systems ◽  
World Health ◽  
Hematopoietic Stem ◽  
Morphological Alterations ◽  
Diagnosis And Classification ◽  
The Moment ◽  
Health Organization ◽  
Selection Of

Myelodysplastic syndromes (MDS) are hematopoietic stem cell disorders characterized by dysplastic, ineffective, clonal and neoplastic hematopoiesis. MDS represent a complex hematological problem: differences in disease presentation, progression and outcome  have necessitated the use of classification systems to improve diagnosis, prognostication and treatment selection. However, since a single biological or genetic reliable diagnostic marker has not yet been discovered for MDS, quantitative and qualitative dysplastic morphological alterations of bone marrow precursors and of peripheral blood cells are still fundamental for diagnostic classification. In this paper World Health Organization (WHO) classification refinements and current minimal diagnostic criteria proposed by expert panels are highlighted and related problematic issues are discussed. The recommendations should facilitate diagnostic and prognostic evaluations in MDS and selection of patients for new effective targeted therapies. Although in the future morphology should be supplemented with new molecular techniques, the morphological approach, at least for the moment, is still the cornerstone for the diagnosis and classification of these disorders.

Psychotic disorders in DSM-5 and ICD-11

CNS Spectrums ◽  
2016 ◽  
Vol 21 (4) ◽  
pp. 349-354 ◽  
Author(s):  
Falko Biedermann ◽  
W. Wolfgang Fleischhacker
Keyword(s):  
Psychotic Disorders ◽  
Work Group ◽  
Theoretical Background ◽  
Classification Systems ◽  
World Health ◽  
Diagnostic And Statistical Manual ◽  
Dsm 5 ◽  
Health Organization ◽  
Diagnostic Criterion

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) was published by the American Psychiatric Association (APA) in 2013, and the Work Group on the Classification of Psychotic disorders (WGPD), installed by the World Health Organization (WHO), is expected to publish the new chapter about schizophrenia and other primary psychotic disorders in 2017. We reviewed the available literature to summarize the major changes, innovations, and developments of both manuals. If available and possible, we outline the theoretical background behind these changes. Due to the fact that the development of ICD-11 has not yet been completed, the details about ICD-11 are still proposals under ongoing revision. In this ongoing process, they may be revised and therefore have to be seen as proposals. DSM-5 has eliminated schizophrenia subtypes and replaced them with a dimensional approach based on symptom assessments. ICD-11 will most likely go in a similar direction, as both manuals are planned to be more harmonized, although some differences will remain in details and the conceptual orientation. Next to these modifications, ICD-11 will provide a transsectional diagnostic criterion for schizoaffective disorders and a reorganization of acute and transient psychotic and delusional disorders. In this manuscript, we will compare the 2 classification systems.

Obsessive compulsive and related disorders: comparing DSM-5 and ICD-11

CNS Spectrums ◽  
2016 ◽  
Vol 21 (4) ◽  
pp. 324-333 ◽  
Author(s):  
Anna Marras ◽  
Naomi Fineberg ◽  
Stefano Pallanti
Keyword(s):  
International Classification Of Diseases ◽  
Classification Systems ◽  
World Health ◽  
Obsessive Compulsive ◽  
Compulsive Disorder ◽  
Dsm 5 ◽  
Classification Of Diseases ◽  
Draft Version ◽  
Health Organization

Obsessive-compulsive disorder (OCD) has been recognized as mainly characterized by compulsivity rather than anxiety and, therefore, was removed from the anxiety disorders chapter and given its own in both the American Psychiatric Association (APA)Diagnostic and Statistical Manual of Mental Disorders(DSM-5) and the Beta Draft Version of the 11th revision of the World Health Organization (WHO)International Classification of Diseases(ICD-11). This revised clustering is based on increasing evidence of common affected neurocircuits between disorders, differently from previous classification systems based on interrater agreement. In this article, we focus on the classification of obsessive-compulsive and related disorders (OCRDs), examining the differences in approach adopted by these 2 nosological systems, with particular attention to the proposed changes in the forthcoming ICD-11. At this stage, notable differences in the ICD classification are emerging from the previous revision, apparently converging toward a reformulation of OCRDs that is closer to the DSM-5.

scholarly journals Beliefs about the cause of schizophrenia among caregivers in Midwestern Nigeria

2017 ◽  
Vol 9 (1) ◽  
Author(s):  
Osayi Igberase ◽  
Esther Okogbenin
Keyword(s):  
Formal Education ◽  
Primary Caregivers ◽  
World Health ◽  
Treatment Seeking ◽  
Benin City ◽  
International Classification Of Disease ◽  
Seeking Behavior ◽  
Icd 10 ◽  
Health Organization

Schizophrenia is a devastating illness with a chronic and relapsing course. While Western countries may endorse, biological and psychosocial causes more commonly than supernatural causes, non-western cultures like Nigeria in contrast, tend to endorse supernatural causes. Belief in supernatural causes has been reported to have consequences for treatment seeking behavior. This study aimed to examine the causes of schizophrenia reported by family members of outpatients with schizophrenia in a neuropsychiatric hospital in Midwestern Nigeria. In this study, we recruited a convenient sample of 200 consecutive caregivers of patients visiting the outpatient department of the Psychiatric Hospital, Benin City, Nigeria. These primary caregivers were unpaid relatives who provided support to patients. The patients were service users who fulfilled the diagnostic criteria of the International Classification of Disease [ICD-10; World Health Organization 1993] for schizophrenia and had been on treatment for at least two years. Majority (72.0%) of caregivers endorsed supernatural causes as most important in the etiology of schizophrenia, while 28.0% endorsed natural causes. Every participant without formal education endorsed supernatural attribution. In our study, it was evident that participants embraced multiple causal attributions for schizophrenia.

scholarly journals Cognitive–behavioural therapy for body dysmorphic disorder

2001 ◽  
Vol 7 (2) ◽  
pp. 125-132 ◽  
Author(s):  
David Veale
Keyword(s):  
World Health Organization ◽  
American Psychiatric Association ◽  
Body Dysmorphic Disorder ◽  
Behavioural Therapy ◽  
World Health ◽  
Cognitive Behavioural ◽  
Icd 10 ◽  
Dsm Iv ◽  
Health Organization

The DSM–IV classification of body dysmorphic disorder (BDD) refers to an individual's preoccupation with an ‘imagined’ defect in his or her appearance or markedly excessive concern with a slight physical anomaly (American Psychiatric Association, 1994). An Italian psychiatrist, Morselli, first used the term ‘dysmorphophobia’ in 1886, although it is now falling into disuse, probably because ICD–10 (World Health Organization, 1992) has discarded it, subsuming the condition under hypochondriacal disorder.

Psychotic Disorders in ICD-11

2013 ◽  
Vol 10 (01) ◽  
pp. 11-17 ◽  
Author(s):  
J. Zielasek ◽  
H.-R. Cleveland ◽  
W. Gaebel
Keyword(s):  
Psychotic Disorders ◽  
Reliability And Validity ◽  
Field Trials ◽  
World Health ◽  
Icd 10 ◽  
Health Organization ◽  
The Impact ◽  
Research Domain ◽  
Specific Working

SummaryWithin the efforts to revise ICD-10, the World Health Organization (WHO) has appointed a disorder-specific Working Group on the Classification of Psychotic Disorders (WGPD). The WGPD has proposed several changes to the classification criteria of schizophrenia and other primary psychotic disorders in order to increase the clinical utility, reliability and validity of the diagnostic classification. The main proposals include changes to the chapter title, the replacement of existing schizophrenia subtypes with symptom specifiers, stricter diagnostic criteria for schizoaffective disorder, a reorganization of the delusional disorders and the acute and transient psychotic disorders, as well as the revision of course specifiers. These proposed revisions are subject to field trials with the aim of studying whether they will lead to an improvement of the classification system in comparison to its previous version. The proposals are compared with revisions of the according DSM-5 chapter. The impact of novel results from neuroscience and genetics on the current proposals is discussed, also with respect to future classification strategies such as the Research Domain Criteria (RDoC) project.

An Overview of the Prospective ICD-10 Classification of Mental Disorders

1989 ◽  
Vol 154 (S4) ◽  
pp. 21-23 ◽  
Author(s):  
J. E. Cooper
Keyword(s):  
Mental Health ◽  
International Classification Of Diseases ◽  
Point Of View ◽  
World Health ◽  
Official Statement ◽  
Classification Of Diseases ◽  
Icd 10 ◽  
The Many ◽  
Health Organization

This paper gives a brief outline of the present state of development of the psychiatric chapter of the tenth revision of the International Classification of Diseases (ICD-10). It is written from the point of view of one of the many consultants to the Division of Mental Health, World Health Organization (WHO), Geneva, and thus is not an authoritative or official statement on behalf of WHO. The responsibility for decisions about ICD-10 Chapter V (F) rests with Dr Norman Sartorius, Director of the Division of Mental Health, though many psychiatrists in many countries have contributed to ICD-10 Chapter V (F), and will continue to do so, since much work is still to be done before the final form is officially agreed and published in about 1990. Before he left WHO, Geneva in September, 1986, Dr Assen Jablensky also carried a great deal of responsibility for the arrangements necessary for the production of the drafts of ICD-10 Chapter V (F) that are now being developed.

Classification of diabetes. World Health Organization 2019. What’s new?

2020 ◽  
Vol 23 (4) ◽  
pp. 329-339
Author(s):  
Irina V. Kononenko ◽  
Olga M. Smirnova ◽  
Aleksandr Y. Mayorov ◽  
Marina V. Shestakova
Keyword(s):  
Molecular Genetic ◽  
Classification Systems ◽  
World Health ◽  
Β Cells ◽  
Appropriate Treatment ◽  
Practical Guidance ◽  
Health Organization ◽  
Selection Of ◽  
Hybrid Forms

The review focuses on the new WHO classification published in 2019. Unlike the previous classification, this classification does not recognize subtypes of T1DM and T2DM and offers new types of diabetes: “hybrid types of diabetes” and “unclassified diabetes”. This classification provides practical guidance to clinicians for assigning a type of diabetes to individuals and choose appropriate treatment (whether or not to start treatment with insulin), particularly at the time of diagnosis. This review presents the variety of forms of diabetes, the features of their clinical picture, and also emphasizes the importance of molecular genetic and immunological studies to identify types of diabetes and determine personalized therapy. The selection of “hybrid forms” of diabetes is due to the fact that the treatment of these types of diabetes has its own characteristics associated with the specific pathogenesis of diseases. However, it is obvious that further studies should relate to the study of the mechanisms of damage and decrease in the function of в-cells. Perhaps future classification systems and, as a consequence, personalized treatment will focus on various mechanisms of damage to β-cells.

Sign in / Sign up

Export Citation Format

Share Document